CRISPR Therapeutics AG
(NASDAQ : CRSP)

( )
CRSP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.80%108.001.1%$623.63m
GILDGilead Sciences, Inc.
2.24%75.880.9%$553.53m
AMGNAmgen Inc.
0.81%176.831.1%$472.09m
REGNRegeneron Pharmaceuticals, Inc.
0.14%381.322.7%$367.77m
BIIBBiogen Inc.
0.69%328.031.2%$319.81m
ALXNAlexion Pharmaceuticals, Inc.
-2.24%111.901.9%$254.48m
NKTRNektar Therapeutics
2.30%55.216.1%$211.68m
VRTXVertex Pharmaceuticals Incorporated
-1.34%141.681.9%$185.36m
ALNYAlnylam Pharmaceuticals, Inc
-2.06%128.2010.0%$179.97m
BLUEBluebird Bio, Inc.
17.91%201.8017.2%$170.21m
ILMNIllumina, Inc.
-1.63%214.113.5%$161.51m
AAgilent Technologies, Inc.
-0.65%66.941.5%$153.46m
INCYIncyte Corporation
0.69%97.252.5%$138.55m
BMRNBioMarin Pharmaceutical Inc.
7.46%88.114.4%$100.29m
JUNOJuno Therapeutics, Inc.
-14.34%50.2413.5%$94.10m

Company Profile

CRISPR Therapeutics AG develops gene-based medicines for patients with serious diseases. Its therapeutic molecular level using the breakthrough genome-editing technology called CRISPR-Cas9. The company was founded by Rodger Novak, Emmanuelle Charpentier and Shaun Patrick Foy in 2014 and is headquartered in Basel, Switzerland.